An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions

Genetics in Medicine

Volumn 6, Issue 1, 2004, Pages 38-47

  Khoury, Muin J ^a   Yang, Quanhe ^b   Gwinn, Marta ^a   Little, Julian ^a,c   Flanders, W Dana ^d  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b National Center for Birth Defects and Developmental Disabilities   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d EMORY UNIVERSITY   (United States)

Author keywords

Epidemiology; Gene environment interaction; Genetic testing; Genomic profiling

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DNA FINGERPRINTING; ENVIRONMENTAL FACTOR; EXPOSURE; GENE LOCUS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE; RARE DISEASE;

DNA FINGERPRINTING; ENVIRONMENT; EPIDEMIOLOGIC STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RISK FACTORS;

EID: 0842305961     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000105751.71430.79     Document Type: Article

References (43)

1. Collins FS, Green ED, Guttmacher AE et al. A vision for the future of genomics research. Nature 2003;422:835-847.
2. Collins FS. Shattuck lecture: Medical and societal consequences of the Human Genome Project. N Engl J Med 1999;341:28-37.
3. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001;285:540-544.
4. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000;343:141-144.
5. Zimmern RL. The human genome project: a false dawn? BMJ 1999;319:1282.
6. Cooper RS, Psaty BM. Genomics and medicine: distraction, incremental progress, or the dawn of a new age? Ann Intern Med 2003;138:576-580.
7. Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002;296:695-698.
8. Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ 2001;322:1052-1056.
9. Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 2001;357:709-712.
10. Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002;156:300-310.
11. Sciona. Discover the relationship between you and your genes. Available at: http://www.sciona.com. Accessed June 1, 2003.
12. Genovations: the advent of truly personalized healthcare. Available at: http://www.genovations.com. Accessed June 1, 2003.
13. Haga S, Khoury MJ, Burke W. Genomic profiling for lifestyle modification: not ready for prime time. Nat Genet 2003;34:347-350.
14. Barrett S, Hall H. Dubious genetic testing: Quackwatch. Available at: http://www.quackwatch.org/01QuackeryRelatedTopics/Tests/genomics.html. Accessed August 5, 2003.
15. Secretary's Advisory Committee on Genetic Testing (SACGT). Enhancing the Oversight of Genetic Tests: Recommendations of the SACGT (2000).Available at: http://www4.od.nih.gov/oba/sacgt/reports/oversight_report.htm. Accessed online, June 2, 2003.
16. Burke W, Atkins A, Gwinn M et al. Genetic test evaluations: information needs for clinicians, policy makers and the public. Am J Epidemiol 2002;156:311-318.
17. Yang Q, Khoury MJ, Botto L et al. Improving the prediction of complex diseases by testing for multiple disease susceptibility genes. Am J Hum Genet 2003;72:636-649.
18. Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet 2002;9340:1155-1162.
19. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002;22:201-210.
20. Stover PJ, Garza C. Bringing individuality to public health recommendations. J Nutr 2002;132(suppl):2476S-2480S.
21. National Cancer Institute. Probability of Developing or Dying of Cancer. Database available at: http://srab.cancer.gov/devcan/canques.html. Accessed June 2, 2003.
22. Mossey PA, Little J. Epidemiology of oral clefts: an international perspective. In: Wyszynski DF, editor. Cleft lip and palate: From origins to treatment. Oxford University Press; 2002:127-158.
23. Holtzman NA, Waston MS, editors. Promoting safe and effective use of genetic testing: Final Report of the Task Force on Genetic Testing, 1997. Available at: http://www.genome.gov/page.cfm?pageID=10001733. Accessed June 2, 2003.
24. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York: Oxford University Press; 1993:77-79.
25. Burke W, Austin M. Genetic risk in context: calculating the penetrance of BRCA1 and BRCA2 mutations. J Natl Cancer Inst 2002;94:1185-1187.
26. van de Vijver MJ, He YD, van't Veer LJ et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer. N Engl J Med 2002;347:1999-2009.
27. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-579
28. Khoury MJ. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 2003;5:261-268.
29. Little J, Khoury MJ, Bradley L et al. The Human genome is complete. How do we develop a handle for the pump? Am J Epidemiol 2003;157:667-673.
30. Klerk M, Verhoef V, Clarke R et al. MTHFR 677C→T Polymorphism and risk of coronary heart disease. A meta analysis. JAMA 2002;288:2023-2031.
31. Nelson MR, Kardia SL, Ferrell RE, Sing CF. A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res 2001;3:458-470.
32. Wald NJ, Law MR. A strategy to reduce cardiovascular risk by more than 80%. BMJ 2003;326:1419-1424.
33. Feuer EJ, Wun LM, Boring CC et al. The lifetime risk of developing breast cancer. JNCI 1993;85:892-897.
34. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;14:32-38.
35. Centers for Disease Control, and Prevention. Physical activity and good nutrition: essential elements to prevent chronic diseases and obesity. At-a-glance 2002. website accessed January 1, 2003 Available at: http://www.cdc.gov/nccdphp/aag/aag_dnpa.htm
36. Centers for Disease Control, and Prevention. Current cigarette smoking among adults aged 18 and older, 2000. Available at: http://www.cdc.gov/tobacco/statehi/html_2002/current_2000.htm. Website January 1, 2003.
37. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.
38. Centers for Disease Control, and Prevention. Trends in Screening for Colorectal Cancer: United States, and 1999. MMWR 2001;50:162-166. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5009a2.htm, 1997. Accessed January 1, 2003.
39. Rockhill B. The privatization of risk. Am J Public Health 2001;91:365-368.
40. Hunt S, Gwinn M, Adams TD. Family history assessment: strategies for prevention of cardiovascular disease. Am J Prev Med 2003;24:136-142.
41. Khoury MJ, McCabe L, McCabe ERB. Population screening in the age of genomic medicine. N Engl J Med 2003;348:50-58
42. Khoury MJ, Adams MJ, Flanders WD. An epidemiologic approach to ecogenetics. Am J Hum Genet 1988;42:89-95.
43. Meijers-Heijboer H, van den Ouweland A, Wasielewski M, et al. Low penetrance susceptibility to breast cancer due to CHECK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002;31:55-59.